Kestra Medical Technologies, Ltd. Overview
Pro stress-test →Kestra Medical Technologies operates as a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company develops and commercializes the Cardiac Recovery System platform, which integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Strategic Profile
Pro stress-test →The flagship ASSURE WCD is a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest, accompanied by a suite of integrated digital solutions and services. Its integrated approach combining advanced monitoring, real-time therapeutic intervention, and comprehensive digital health support differentiates it in the competitive landscape of medical device technology.
Competitive Landscape
Pro stress-test →Kestra competes against approximately 40 competitors including CardioDiagnostics and other cardiac monitoring/therapeutic device companies. The company differentiates through its integrated platform combining wearable hardware with digital health services and clinical support, rather than point solutions. Primary competitors include traditional ICD manufacturers and emerging digital cardiac care platforms.
Industry Context
Kestra Medical Technologies, Ltd. operates in Wearable Medical Devices / Digital Healthcare / Cardiovascular Medical Device.
Key facts
Founded: 2014 · Headquarters: Kirkland, Washington, United States · Revenue: $59.82M (FY2025) · Market cap: $1.2B